.Repare Therapeutics is laying off a quarter of its staff as the oncology biotech lessen its own pre...
.Johnson & Johnson has taken one more action toward noticing a return on its own $6.5 billion nip...
.Gain Therapies has actually set its own direct proving the performance of its own Parkinson's condi...
.Actinogen Medical's chances-- and also sell cost-- have rebounded somewhat coming from earlier this...
.Crown Jewel Pioneering and Pfizer have included Ratio into their 10-program collaboration, inking a...
.Bayer executives were actually eager to stress and anxiety to Tough this summer months that the Ger...
.Amidst a yearslong clinical trial decrease in the U.K., a new public-private relationship has devel...
.Complying with the news of a big layoff shot in April and a significant rebuilding campaign introdu...
.Neurocrine Biosciences has attained its hoped-for account in a stage 2 mental illness test, providi...
.Vaderis Rehabs' target to develop the first medication aimed exclusively at a specific rare capilla...